Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT02427893
Title Trial of Vemurafenib and Cobimetinib in Patients With Advanced BRAFV600 Mutant Melanoma
Recruitment Withdrawn
Gender both
Phase Phase III
Variant Requirements Yes
Sponsors Sidney Kimmel Comprehensive Cancer Center
Age Groups: adult
Covered Countries USA

Additional content available in CKB BOOST